&#226;€‹Biopharmaceutical company.
Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies. Appropriations issues related H.R. 4356 - the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2022, pertaining to FDA enforcement of non-FDA approved CBD products. Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies.
HCR - Health Issues BUD - Budget/Appropriations MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO EMILY KIRLIN MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO EMILY KIRLIN MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO EMILY KIRLIN